Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Lord's Mark Industries Reports ₹82 Crore Profit in H1 FY27 with Q2 Growth

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Lord's Mark Industries Reports ₹82 Crore Profit in H1 FY27 with Q2 Growth

Analysed 16 Nov 2026·2 sources analysed·United Kingdom·Business
Lord's Mark Industries Reports ₹82 Crore Profit in H1 FY27 with Q2 GrowthPreviousNext

Lord's Mark Industries reported a consolidated revenue of ₹718.77 crore and a PAT of ₹82.01 crore for H1 FY27, surpassing its full-year FY26 revenue and profit. Q2 revenue rose 34% quarter-on-quarter to ₹411.09 crore, with PAT increasing 47%. EBITDA margin improved to 18.8% in Q2. The company plans to launch dialysis exports, sickle cell and breast cancer screening products, and expand sales in the UK, US, and Caribbean between December 2026 and March 2027.

Sentiment
76%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (76/100). Lens Score 44/100.

Outlets measured: news18, thetribune. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 16 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (76/100)

Sentiment was consistent across outlets (75–78/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

thetribune broke this story on 16 Nov, 11:54 am. Other outlets followed.

16 Nov, 11:54 am2 sources · 64 min16 Nov, 12:58 pm
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Tight Global Diesel Supplies Support Indian Refiners’ Margins Amid Market Shifts
Next →
IMGC and KIFS Partner to Enhance Access to Affordable Home Loans in India
1
thetribune16 Nov, 11:54 am
Lord's Mark Industries H1 FY27 Profit Hits inr 82 Crore - 1.7x Its Entire FY26; Q2 PAT Jumps 47 percentage Over Q1, AI Dialysis, Cancer Screening and US-UK Launches Line Up for 2027
  • 2
    news1816 Nov, 12:58 pm
    Lord's Mark Industries Reports 82 Crore H1 FY27 Profit; Q2 PAT Rises 47 QoQ
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Lords Mark Industries Inc.Lords Mark Tech Next Private LimitedRenalyx Health Systems Private LimitedLords Mark Micro Biotech Private LimitedLord's Mark Industries LimitedLords Green Energy Private Limited

    Story context

    Category
    Business
    Location
    United Kingdom
    Sources analysed
    2
    Last analysed
    16 Nov 2026
    Key entities
    Kidney dialysisLord'sMedical deviceEarnings before interest, taxes, depreciation, and amortizationRevenueCroreIndian rupeeCaribbeanUnited KingdomHealth careBombay Stock ExchangeIndia